Academic literature on the topic 'ECMO (médecine) – Complications (médecine)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ECMO (médecine) – Complications (médecine).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "ECMO (médecine) – Complications (médecine)":
Dadon, Michel. "Médecine esthétique du visage et complications vasculaires." JMV-Journal de Médecine Vasculaire 47 (March 2022): S39. http://dx.doi.org/10.1016/j.jdmv.2022.01.012.
Bouzidi, M., B. Arfaoui, S. Sayhi, N. Gueddiche, F. Ajili, and N. Ben Abdelhfidh. "Corticoïdes et complications métaboliques en médecine interne." Annales d'Endocrinologie 84, no. 5 (October 2023): 609. http://dx.doi.org/10.1016/j.ando.2023.07.289.
Le Guen, M., and T. Loeb. "Extracorporeal membrane oxygenation (ECMO) en médecine d’urgence : une technique non ordinaire pour des indications assez ordinaires." Journal Européen des Urgences et de Réanimation 27, no. 4 (December 2015): 173–75. http://dx.doi.org/10.1016/j.jeurea.2015.10.006.
Renouard, Franck, and Edith Perrault-Pierre. "Le comportement humain : première cause de complication en pratique médicale ?" L'Orthodontie Française 87, no. 1 (March 2016): 3–11. http://dx.doi.org/10.1051/orthodfr/2015037.
Sakarovitch, B., S. Monnier, R. Meckenstock, A. Therby, D. Khau, and A. Greder-Belan. "Médecine interne et complications aiguës : comment mieux assister les services d’accueil des urgences ?" La Revue de Médecine Interne 35 (December 2014): A96—A97. http://dx.doi.org/10.1016/j.revmed.2014.10.155.
Brousse, G. "Les nouvelles drogues de synthèse aux urgences : aspects épidémiologiques et cliniques, principes de prise en charge." European Psychiatry 30, S2 (November 2015): S60. http://dx.doi.org/10.1016/j.eurpsy.2015.09.166.
MESSAADI, N., S. CHALLOUT, C. VINCENT, M. BUBROVSKY, S. DUHEM, CL CHARREL, L. ZERHOUI, and S. BAYEN. "Proportion d’élèves susceptibles d’être victimes de harcèlement scolaire consultant en médecine générale. Protocole de recherche." EXERCER 35, no. 203 (May 1, 2024): 206–11. http://dx.doi.org/10.56746/exercer.2024.203.206.
Nahon, S. "Prise en charge des patients ayant une maladie inflammatoire chronique de l’intestin hospitalisés en médecine intensive et réanimation." Médecine Intensive Réanimation 27, no. 4 (June 22, 2018): 309–16. http://dx.doi.org/10.3166/rea-2018-0045.
Kepka, S., T. Marx, and T. Desmettre. "Le drainage thoracique aux urgences dans la prise en charge d’un épanchement pleural non traumatique." Annales françaises de médecine d’urgence 9, no. 4 (July 2019): 261–68. http://dx.doi.org/10.3166/afmu-2019-0178.
Emery, C., F. Lançon, F. Fagnani, M. Pechevis, I. Durand, and D. Floret. "Prise en charge de la varicelle et de ses complications en médecine ambulatoire en France : l'étude ENVOL." Médecine et Maladies Infectieuses 36, no. 2 (February 2006): 92–98. http://dx.doi.org/10.1016/j.medmal.2005.12.001.
Dissertations / Theses on the topic "ECMO (médecine) – Complications (médecine)":
Moussa, Mouhamed Djahoum. "Déterminants cliniques, physiopathologiques et pronostics associés aux complications liées à l’hémostase au cours des assistances circulatoires de courte durée à pompe centrifuge." Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS055.
The purpose of this dissertation is to characterize hemostasis-related complications in patients supported by peripheral VA-ECMO to improve their prevention and to optimize the antithrombotic therapeutic approaches in use. In a first study, we qualitatively and quantitatively described the composition of thrombi collected from the VA-ECMO circuits. We observed that these thrombi are mainly made of VWF, fibrin and in a lesser proportion of platelets and RBCs. Our quantitative approach also allowed us to demonstrate the presence of NETs while there was no active septic, confirming the possibility of aseptic NETosis under VA-ECMO. By hierarchical cluster analysis, we identified 2 types of thrombi, each of which may be related to a different mechanism of formation. In this study, the location of thrombi on the VA-ECMO circuit did not impact their compositions, highlighting the heterogeneity of thrombi formed within VA-ECMO and the multifactorial mechanisms that support thrombosis in this setting. In a second study, we compared the performance of surface coatings on VA-ECMO circuits to reduce thrombinoformation and its clinical consequences. Two of the most used coatings in daily practice were compared: the phosphorylcholin-based coating and the polysaccharide-albumin-based coating. We observed a higher rate of thrombotic complications in the phosphorylcholin group without any excess bleeding events or mortality in either group. In addition, compared with thrombi from phosphorylcholin-coated circuit junctions, those from polysaccharide-albumin-coated circuits were poorer in VWF. Our work suggests that the level of anticoagulation should be modulated according to the type of coating of the ECMO circuit.The aim of our third study was to identify the most relevant bleeding events that may guide clinical decision-making for more aggressive clinical management and a greater investment in research. To this end, we compared the association between 3 bleeding classifications with 28-day mortality. The ELSO definition already in use and the BARC classification classes ≥ type 2 were associated with 28-day mortality and thus retained as definitions of major bleeding. Laboratory parameters that are predictors major bleeding according to the ELSO definition were decreased fibrinogen, platelet count, and hemoglobin at cannulations. Body mass index and postcardiotomy etiology were also predictive of ELSO major bleeding. In an additional work related to the topic of the thesis, we studied two of the most used laboratory tests for the monitoring of systemic heparin during VA-ECMO, the APTT and the Anti-Xa activity, to identify the most relevant. First, we studied the relationship between these two tests and then analyzed in a second objective the impact of biological influencing factors on this relationship. Next, we determined their associations with thrombotic and hemorrhagic complications. Although linearly associated, the rate of discordance between their measurements was 39 % for an Anti-Xa reference range of 0.3 - 0.7 IU/mL. Neither APTT nor Anti-Xa was associated with thrombotic or bleeding complications. Taken together, our results highlight the heterogeneity of thrombi from peripheral VA-ECMO, the involvement of numerous causal factors that underline thrombotic and hemorrhagic complications, both not predictable by routine tests. Finally, our work underscored the need for new approaches in thrombotic or hemorrhagic complications management with targets set at an individual level considering both patient and ECMO circuit characteristics
Fernandez, Calahorra Francisco Javier. "Conversions et complications dans la cholecystectomie par laparoscopie : à propos d'une série consécutive de 393 opérés." Bordeaux 2, 1992. http://www.theses.fr/1992BOR23099.
Joannes, Marie-Odile. "Recherche de polymorphysmes génétiques associés à des complications majeures de pathologies prédominantes en Martinique et en Guadeloupe : la drépanocytose et le diabète." Antilles-Guyane, 2009. http://www.theses.fr/2009AGUY0269.
SICKLE CELL DISEASE (SCD) AND DIABETES MELLlTUS ARE LEADING CAUSES OF MORBIDITY IN MARTINIQUE AND GUADElOUPE. BECAUSE OF THE ASSOCIATION OF SOME GENETIC POLYMORPHISMS AND PATHOlOGIES, WE WONDERED IF SOME GENETIC POLYMORPHISMS COULD PREDICT COMPLICATIONS IN SICKLE CELL PATIENTS AND TYPE 2 DIABETIC WE INVESTIGATED POLYMORPHISM OF GENES INVOLVED IN THE IMMUNE SYSTEM (MYELOPEROXYDASE, HLA, TNF ALPHA, IFN GAMMA, IL6 AND IL10) AS MODULATORS OF INFECTIOUS COMPLICATIONS IN SCD. WE ALSO TRIED TO FIND AN ASSOCIATION BETWEEN FABP2 POLYMORPHISM, METABOLIC SYNDROME AND CARDIOVASCULAR COMPLICATIONS IN T2D SUBJECTS. OUR RESULTS REVEALED AN ASSOCIATION BETWEEN MYELOPEROXIDASE POLYMORPHISM AND INFECTIOUS COMPLICATIONS IN SICKLE CELL PATIENTS JUST AS IFNr POLYMORPHISM. ON THE OTHER HAND, HLA-DRB1*11 COULD HAVE A PROTECTIVE EFFECT AGAINST INFECTIONS. MOREOVER, OUR RESULTS HIGHLIGHTED A PREDOMINANT COMBINATION OF DYSLlPIDEMIA AND OBESITY IN T2D PATIENTS CARRYING THE THREONINE VARIANT OF FABP2
Gérard, Sonia. "Complications maternelles des césariennes." Rouen, 1990. http://www.theses.fr/1990ROUE104M.
Tiprez-Chocoloff, Catherine. "La reconstruction vasculaire après oxygénation extracorporelle en période néonatale : à propos de 26 observations." Lille 2, 1995. http://www.theses.fr/1995LIL2M105.
Courtault, Carine. "Complications des fibrinolyses de thromboses de prothèses mécaniques de valves cardiaques." Bordeaux 2, 2001. http://www.theses.fr/2001BOR2M070.
Gayraud, Laurence. "Bronchiolite oblitérante au cours des transplantations pulmonaires et cardiopulmonaires : apport de la TDM-HR." Bordeaux 2, 1993. http://www.theses.fr/1993BOR23054.
Meyrat, Léon. "Les complications graves des sinusites ethmoidales et frontales : place du traitement médical et chirurgical." Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M126.
Narbey, Noëlle. "Rechute fébrile attribuée à une méningoencéphalite herpétique dans les suites d'un neuropaludisme : complication ou coincidence ? à propos d'un cas." Bordeaux 2, 1995. http://www.theses.fr/1995BOR2M100.
Gouget, Anne-Marie. "Le trouble somatisation." Bordeaux 2, 1997. http://www.theses.fr/1997BOR2M118.
Books on the topic "ECMO (médecine) – Complications (médecine)":
Barron, William M. Médecine de la femme enceinte. Paris: Flammarion Médecine-Sciences, 1990.
Olivennes, François. Tout ce qu'il faut savoir avant une grossesse. Paris: Marabout, 2013.
Jankowski, Janusz A. Z. Inflammation and Gastrointestinal Cancers. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.
Vincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Beck, Leslie. The complete nutrition guide to menopause: Natural strategies to manage symptoms, control weight and stay healthy. Toronto: Penguin Canada, 2008.
Cook, Robin. Host. New York: G. P. Putnam's Sons, 2015.
Delcourt, Marie. Stérilités mystérieuses & naissances maléfiques dans l'antiquité classique. Paris: Les belles lettres, 1986.
Vincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Maté, Gabor. When the body says no: Exploring the stress-disease connection. Hoboken, N.J: J. Wiley, 2011.
Maté, Gabor. When the body says no: The cost of hidden stress. Toronto: A.A. Knopf Canada, 2003.
Book chapters on the topic "ECMO (médecine) – Complications (médecine)":
Santin, A., and B. Renaud. "Drépanocytose et complications aiguës." In Maladies rares en médecine d’urgence, 279–301. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_17.
Mouthon, L. "Traitements immunomodulateurs et complications spécifiques." In Maladies rares en médecine d’urgence, 43–64. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_4.
Mouthon, L. "Principaux immunosuppresseurs et complications spécifiques." In Maladies rares en médecine d’urgence, 65–87. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_5.
Arnulf, B. "Complications aiguës des syndromes lymphoprolifératifs." In Maladies rares en médecine d’urgence, 89–107. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_6.
Guedj, M., and D. Monnet. "Complications ophtalmologiques aiguës des maladies systémiques." In Maladies rares en médecine d’urgence, 221–39. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_14.
Berezne, A., G. Bussone, and L. Mouthon. "Complications aiguës de la sclérodermie systémique." In Maladies rares en médecine d’urgence, 109–24. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_7.
Terrier, B., and V. Le Guern. "Complications aiguës du lupus érythémateux systémique." In Maladies rares en médecine d’urgence, 125–37. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_8.
Charles, P., and X. Puéchal. "Complications aiguës des vascularites associées aux ANCA." In Maladies rares en médecine d’urgence, 139–52. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_9.
Olivier, Pierre-Yves, Julien Demiselle, Pierre Asfar, Alain Mercat, and Nicolas Lerolle. "ECMO veino-veineuse et veino-artérielle : surveillance et complications." In Petit manuel de survie en médecine intensive-réanimation, 126–29. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77693-9.00037-x.
Vaillant, L. "Complications des Lymphœdèmes." In Traité de médecine vasculaire., 291–95. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-71346-0.50007-0.